There are too many outstanding shares for GILD to move much in AH. (smaller the float the greater the move, opposite happens with a huge float). Tomorrow action will be more telling.
Someone will to explain this one to me. I get that India impacted Comverse negatively, but overall is sounds,like their are delayed orders which will pick up in the next quarter. The small float and low daily volume has likely helped this move through some support level. Still, looks worth taking a flyer..at 10 PE
"We have grown year-over-year product bookings in two of our three geographies. However, we faced significant softness in our Asia Pacific region resulting in an overall decline in bookings compared to fiscal 2012. This softness was primarily a function of the overall economic conditions in India and a delay in orders with a large customer in the region. We believe we have a tremendous portfolio of products and a significant install base to drive future growth.
Imperva price target lowered to $45 from $57 at Stephens
Stephens lowered its price target on Imperva to $45 after the company's preliminary Q1 results came in below expectations, but the firm believes the Q1 miss was timing related and that Imperva's growth can reaccelerate. The firm maintains its Overweight rating on the stock.
This is a low float, low volume stock.. It doesn't take much to move a stock like this, especially in AH.
Loss expected to be .40 , initial estimates were -.32 to -.37. Loss was expected, a little higher with some sales pushed out. Reaction extreme, but its in the hands of traders now.
Overall, the news is not as bad as the stock movement would indicate.
This was going down to test 80 no matter what. Surprising that it tested in one fell swoop, in the same trading day.
With 208M in cash, and annual revenues of only 337M, I was wondering how they were going to finance this acquisition of 567M. Then I found this tidbit in their announcement:
"The transaction consideration is subject to certain adjustments as provided in the definitive agreement and a substantial portion of the purchase price will be debt financed."
They will have to issue more stock and a secondary to finance the debt before the acquisition. That makes BCPC a great short opportunity at $62, in the near term.
It is hard to say where this will open since the short interest may have an effect tomorrow. In general the FY14 estimated EPS is in line with what was expected. The PE is too high for RH industry. This should really be in the 40' or 50's, but that won't happen tomorrow.
PE, forward PE and PEG are all very reasonable. Actually pretty low from the drubbing that GME had the last 6 months, Based on the low PE, I think that earnings will be viewed as a relief.
PE almost 90, forward PE 38?? fundamentals say this is priced too high. The high level of short interest is keeping this afloat in early trading.
With FIVE basically meeting analysts expectations for next year, it appears FIVE is priced a little steep.
Its PE is 77.55, Forward P/E, PEG Ratio is 1.86. All pretty high for its industry.
The high short ratio may the only reason this is propped up in AH.
The news obviously has investors unhappy. But SYMC's PE , forward PE and PEG indicate a buy here. PE of 15 and forward PE of 10 are rediculously low for a comapny like SYMC.
100M almost doubles their market cap. They are only up 55% in AH. Not sure where you expect this to end up. But 100M will do a lot for shareholder value.
I went long AH under $13. The words that people initially see like "restate", generally causes some panic. But it appears all that will end up happening is redistrubuting of revenue into different quarters. Not good for PR, not structurally bad though.
MX has taken a hit already with the delay. Some clarity is starting to appear. WIth a ridiculously low PE, forward PE, and PEG, this looks a good risk/reward entry point.